BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

MBL International Introduces AngioPhase(TM) Angiogenesis Kit


2/9/2012 2:41:15 PM

WOBURN, Mass., Feb. 9, 2012 /PRNewswire/ -- MBL International Corporation, a leading life science company focused on providing high quality products and solutions for life science research and clinical diagnostics, today announced the launch of AngioPhase, an angiogenesis kit which allows for the analysis of all known phases of the angiogenic process in a convenient and flexible format.

Angiogenesis is the multistep process whereby new blood vessels develop from pre-existing vasculature. It plays a key role in the natural process of healing and reproduction but also in many pathological processes including cancer, skin diseases, age-related blindness, diabetic ulcers, cardiovascular disease, and stroke.

AngioPhase incorporates a patented technology, developed by TCS Cellworks Limited, Buckingham, UK, in which human endothelial cells are co-cultured with other human cells in a specially designed medium. Under the terms of the non-exclusive agreement with TCS Cellworks Limited, MBL International Corporation has been granted a license to manufacture and sell the assay in North and South America.

"MBL International is excited about adding AngioPhase to our growing portfolio of life sciences products," said Dennis Walczewski, CEO MBL International Corporation. "This technology offers many benefits to researchers in the biotechnology and pharmaceutical industries by offering a ready-to-use angiogenesis kit in which test compounds can be added at any time. Moreover, both angiogenic simulators and inhibitors can be assessed as well as tubule formation."

"We are pleased to enter into this licensing agreement with MBL International Corporation," stated Tim Almond CEO of TCS Cellworks. "They have demonstrated not only a strong commitment to manufacturing high quality products but also an impressive business model which leverages the superior technical expertise of their commercial team."

About MBL International Corporation

MBL International Corporation is a leading life science company focused on providing high quality products and solutions for life science research and clinical diagnostics. Our products are used widely in academic research institutions, pharmaceutical and biotechnology companies, government agencies, as well as hospital and reference laboratories. By providing a consultative approach, superior technical and customer support, and convenient purchasing options, MBL International Corporation is your partner in solving your scientific and clinical challenges.

For more information visit http://www.mblintl.com or call 800-200-5459.

About TCS Cellworks Limited

TCS Cellworks is a UK based cellular biology company specializing in the development and application of human primary cell tissue models for the bioscience and pharmaceutical business sectors. The success of the AngioPhase kit in Europe is now being expanded to other markets through carefully selected business partners. TCS also acts as a distributor for a number of international manufacturers in the cell biology field. For further information visit http://www.tcscellworks.co.uk or call 0044 1280 827475.

SOURCE MBL International Corporation



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES